Unintentional weight loss and malnutrition

01OverviewDefinition, clinical context and the essential points that orientate the chapter.

Unintentional weight loss is a symptom, malnutrition a clinical state, and cachexia a metabolically driven syndrome not fully reversed by calories alone. Establish the baseline and trajectory using objective records where possible. Percentage loss is more informative than a single weight; NICE nutrition support criteria include BMI below 18.5 kg/m², unintentional loss above 10% over three to six months, or BMI below 20 with loss above 5%. These thresholds prompt assessment, but clinical concern, frailty and reduced intake can justify action before a threshold is crossed.

The differential spans cancer, chronic infection, gastrointestinal and pancreatic disease, thyroid or adrenal disease, diabetes, cardiopulmonary or renal failure, neurological dysphagia, depression, dementia, eating disorder, alcohol or drug use, medicine adverse effects, dental problems and poverty or isolation. Ask whether appetite is absent, food is unavailable, swallowing is difficult, eating causes pain or diarrhoea, or weight falls despite normal intake. Examination should assess hydration, oral cavity, lymph nodes, abdomen, organomegaly, muscle and fat stores, oedema and functional strength.

Nutrition intervention should run alongside cause-finding. Record goals such as strength, wound healing, treatment tolerance or comfort. Food-first advice and oral supplements require dietetic tailoring, including cultural preferences and diabetes or renal restrictions. Enteral and parenteral routes have mechanical, metabolic and infectious risks and need an MDT. Refeeding syndrome is preventable: identify risk before calories, provide thiamine and multivitamins, correct or closely replace phosphate, potassium and magnesium, start energy cautiously and monitor fluid and cardiac status.

Key points

Verify measured weights, timeframe, percentage change and fluid shifts; a patient's concern matters even when the available chart is incomplete.
Malnutrition is not synonymous with low BMI: oedema and obesity can conceal major muscle loss, while ascites can make weight appear stable.
Separate reduced intake, impaired absorption, increased requirements or losses, and catabolic disease; more than one mechanism commonly coexists.
Dysphagia, gastrointestinal bleeding, jaundice, a mass, persistent vomiting, progressive pain or site-specific cancer features require the current urgent referral pathway.
Screen with a validated tool and assess function, muscle, dentition, swallowing, food access, mood, alcohol and medication effects rather than ordering tests alone.
People who have eaten little or nothing for more than five days need cautious introduction of support; those at high refeeding risk need specialist feeding, thiamine and electrolyte planning.
Use the gut when it is functional and safe: oral optimisation first where possible, enteral feeding when intake is inadequate or unsafe, and parenteral support when the gastrointestinal route is inadequate or inaccessible.
Nutrition support requires consent, shared goals and review; capacity, eating disorders, neglect and food insecurity need sensitive specialist or safeguarding involvement.

02AetiologyUnderlying causes, associations and risk factors, with why each one matters.

Reduced intake

Dysphagia, pain, nausea, dental disease, depression, dementia, poverty and restrictive eating reduce energy intake through different reversible or progressive mechanisms.

Malabsorption and gastrointestinal loss

Coeliac disease, pancreatic insufficiency, IBD, chronic diarrhoea and postoperative anatomy prevent nutrient uptake or increase ongoing losses.

Catabolic systemic disease

Cancer, infection, inflammatory disease, hyperthyroidism and advanced organ failure raise metabolic demand or accelerate tissue breakdown despite apparently adequate intake.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.

1
Negative energy and protein balance
Energy expenditure and losses exceed absorption, forcing use of glycogen, fat and eventually skeletal-muscle protein for energy and gluconeogenesis.
2
Inflammatory catabolism
Cytokines suppress appetite, increase resting expenditure and impair anabolic response, so nutritional supplementation alone may not reverse wasting.
3
Micronutrient and functional decline
Cumulative vitamin and mineral deficits impair blood formation, immunity, nerves, bone and muscle, reinforcing frailty and reduced intake.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.

Cancer or structural alarmRed flag

Progressive dysphagia, iron-deficiency anaemia, rectal bleeding, jaundice, palpable mass, persistent vomiting, focal pain or new change in bowel habit with weight loss requires the live NICE suspected-cancer pathway.

Severe malnutritionRed flag

Very low BMI, rapid loss, visible muscle wasting, weakness, pressure damage, recurrent falls, poor wound healing, oedema or inability to maintain intake indicates high physiological risk even if routine blood tests are normal.

Refeeding riskRed flag

Little or no intake, very low BMI, major recent weight loss, low phosphate, potassium or magnesium, harmful alcohol use, or medicines such as insulin, chemotherapy, antacids or diuretics can place a patient at high risk.

Swallowing and aspiration problemRed flag

Coughing with meals, wet voice, recurrent chest infections, food sticking, odynophagia or neurological disease requires distinction between oropharyngeal and oesophageal dysphagia and prompt speech-and-language or endoscopic assessment.

Psychosocial or safeguarding driver

Depression, cognitive impairment, fear of weight gain, self-neglect, coercion, inability to shop or cook, poverty and social isolation can drive malnutrition and should be explored privately and non-judgementally.

05InvestigationsWhat to request, why it matters and how to interpret it.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
Measured nutrition assessmentFirst step
Why
Record current and previous weights, height, BMI, percentage loss, intake history, MUST or another validated score, grip or functional change, muscle and fat loss, oedema and hydration.
Interpretation and limitations
Fluid accumulation can mask tissue loss. A screening score identifies risk but does not diagnose the cause or replace clinical assessment.
02
Initial blood profile
Why
Use FBC, CRP or ESR, renal and liver profile, calcium, glucose or HbA1c, thyroid tests, ferritin and haematinics, adding HIV or other tests with consent and exposure rationale.
Interpretation and limitations
Normal blood tests do not exclude cancer or malnutrition. Low albumin commonly reflects inflammation or fluid distribution and is not a stand-alone nutrition marker.
03
Refeeding baseline
Why
Check phosphate, potassium, magnesium, glucose, renal function, fluid status and ECG where severe electrolyte or cardiac risk exists before substantial nutrition starts.
Interpretation and limitations
Normal initial electrolytes do not eliminate refeeding risk because intracellular depletion may become apparent after insulin-driven feeding.
04
Cause-directed imaging and endoscopy
Why
Follow symptom-specific urgent cancer pathways and use chest imaging, abdominal CT or ultrasound, gastroscopy, colonoscopy or other tests according to history and examination.
Interpretation and limitations
A non-specific whole-body investigation may miss the immediate swallowing, social or intake problem; each test should answer a stated question.
05
Swallow assessment
Why
Request bedside and specialist speech-and-language assessment for oropharyngeal symptoms and upper GI evaluation for oesophageal obstruction or mucosal disease.
Interpretation and limitations
A safe texture recommendation is individual and can change; an oesophageal 'sticking' history is not resolved by modifying drinks alone.
06
Dietetic and psychosocial assessment
Why
Quantify energy and protein intake, micronutrient risk, food access, cooking ability, mood, cognition, alcohol, body-image concerns and the patient's goals.
Interpretation and limitations
The feasibility and ethics of a feeding plan depend on capacity, preferences, support and prognosis as well as calculated requirements.

06Differential diagnosisRealistic alternatives and the features that help distinguish them.

Malignancy

Progressive loss with bleeding, dysphagia, jaundice, mass, persistent vomiting or site-specific symptoms requires the current suspected-cancer pathway.

Endocrine or inflammatory disease

Thyroid symptoms, hyperglycaemia, fever, raised inflammatory markers and organ-specific findings support metabolic, infectious or immune catabolism.

Mental health and social causes

Low mood, body-image fear, cognitive impairment, food insecurity and neglect require direct non-stigmatising assessment while organic disease is still considered.

07ManagementImmediate care, first-line treatment, alternatives and escalation.

01TriageWeight loss with alarm featuresFirst stepObjective or credible weight loss accompanies a cancer, obstruction, infection or organ-failure warning sign.

1EscalationAssess urgency, hydration, sepsis, bleeding, aspiration and electrolyte disturbance; admit or escalate on the same day when unstable or unable to maintain intake.
2Use the current NICE symptom- and age-specific suspected-cancer recommendation rather than relying on a remembered threshold.
3Start proportionate nutrition and symptom support while investigation proceeds, with dietetic and swallowing input where relevant.
4Create a result and referral owner so an urgent diagnostic pathway does not leave malnutrition untreated.

02RefeedHigh-risk nutrition initiationSevere depletion, negligible intake or NICE high-risk features for refeeding problems.

1Seek an experienced dietitian or nutrition-support team, document baseline fluid state, ECG risk and phosphate, potassium, magnesium and glucose.
2Give thiamine and balanced micronutrient supplementation before and during early feeding as the current protocol specifies.
3Start energy cautiously, often no more than 10 kcal/kg/day in high-risk patients and lower in extreme risk, while providing appropriate electrolyte replacement.
4EscalationIncrease over several days with close clinical and biochemical monitoring; slow or pause escalation for fluid overload, arrhythmia or severe electrolyte change.

03SupportChoose the feeding routeNutrition support is indicated after goals, reversibility and consent have been considered.

1Optimise normal food, assistance, symptoms and oral supplements when swallowing is safe and intake can meet needs.
2Use enteral tube feeding when oral intake is inadequate or unsafe but the gastrointestinal tract is functional and accessible.
3Use parenteral nutrition when oral or enteral intake is inadequate or unsafe and gastrointestinal function or access prevents enteral delivery.
4Review route, tolerance, complications and ongoing indication regularly, including whether support remains aligned with the person's goals.

Key medicines and prescribing safety3 treatments · regimens, roles and cautions

Reduces the risk of thiamine-deficiency complications when carbohydrate delivery increases.

Thiamine with balanced vitamin supplementation

For high refeeding risk, NICE describes oral thiamine 200 to 300 mg daily immediately before and during the first 10 days of feeding, with vitamin B co strong and a balanced multivitamin or trace-element supplement; use the local protocol.

Give before calories where possible; use an intravenous regimen when Wernicke encephalopathy is suspected or oral absorption is unreliable. Do not let vitamin prescribing delay urgent feeding-team review.

Adds energy and protein when food-first measures alone are insufficient and swallowing is safe.

Oral nutritional supplement

Dietitian-selected product and volume to close the documented energy, protein and micronutrient gap, usually between meals rather than replacing tolerated food.

Consider diabetes, renal or liver disease, fluid restriction, allergies, texture safety and adherence. Supplements do not treat obstruction, malabsorption or cachexia by themselves.

Prevents or treats electrolyte shifts during refeeding and corrects pre-existing depletion.

Phosphate, potassium and magnesium replacement

Use current local oral or intravenous replacement protocols based on the measured level, renal function, symptoms, ECG and feeding trajectory.

Intravenous replacement can cause arrhythmia, hypotension, tissue injury or overcorrection. Renal impairment changes dosing and monitoring; replacement should accompany feed adjustment.

08ComplicationsImportant consequences, why they occur and why they matter clinically.

Frailty, falls and poor healing

Muscle and protein loss reduce mobility, respiratory reserve, immunity and wound repair, increasing falls, pressure injury and treatment toxicity.

Micronutrient organ injury

Iron, vitamin B12, folate, thiamine, vitamin D and electrolyte deficits cause anaemia, neuropathy, bone disease, delirium and arrhythmia.

Refeeding syndrome

Rapid carbohydrate delivery after prolonged depletion can trigger phosphate, potassium, magnesium, thiamine and fluid shifts with cardiac, respiratory or neurological failure.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.

Measure weight at a meaningful frequency with consistent conditions, while tracking oedema, ascites and hydration so fluid change is not mistaken for tissue gain.
Document actual food, supplement and feed delivery rather than prescribed amounts, plus nausea, pain, diarrhoea, aspiration and tube or line complications.
During early refeeding, monitor phosphate, potassium, magnesium, glucose, renal function and fluid balance at the protocol-defined frequency.
Assess pulse, blood pressure, respiratory status, oedema and ECG or rhythm when severe refeeding or electrolyte risk exists.
Reassess muscle function, mobility, pressure areas, wound healing and ability to shop, cook and eat, not only BMI.
Track the investigation pathway and revisit the differential if weight continues to fall despite apparently adequate intake.
Review capacity, consent, distress and goals whenever the burden or route of nutrition support changes.

10Special situationsVariants, exceptions and circumstances that change the usual approach.

Albumin is not a nutrition score

Inflammation, capillary leak, renal loss and liver disease all lower serum albumin. It predicts illness severity better than isolated protein intake.

Oedema can conceal starvation

A patient may gain scale weight while muscle and intracellular electrolytes decline. Bedside examination and intake history expose the mismatch.

Cachexia needs disease treatment

Inflammatory catabolism limits the response to calories alone. Treating cancer or organ failure, symptoms and activity may matter alongside nutrition.

Route follows physiology

A functioning accessible gut generally favours enteral delivery, but aspiration risk, obstruction, tolerance and patient preference can alter the decision.

Refeeding begins before the feed

Risk recognition, thiamine, electrolyte planning and fluid assessment should be complete before a substantial carbohydrate load is prescribed.

11Common pitfallsFrequent interpretation and management errors.

01
Assuming stable weight excludes malnutrition in a patient with oedema or ascites.
02
Ordering extensive imaging while missing dysphagia, dental pain or inability to afford food.
03
Starting full-calorie feeding immediately after prolonged negligible intake.
04
Using albumin alone to diagnose or monitor malnutrition.
05
Treating a supplement prescription as proof that the patient consumes it.
06
Stopping an urgent cancer investigation because weight improves briefly.